基瓦尼科技 2025年度报告

FORM 10-K__________________________ ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934For the fiscal year ended April30, 2026 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the transition period from __________ to __________Commission file number 0-5286 KEWAUNEE SCIENTIFIC CORPORATION(Exact name of registrant as specified in its charter) __________________________ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submitsuch files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, oran emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growthcompany" in Rule 12b-2 of the Exchange Act: Accelerated filer☐Smallerreportingcompany☒Emerginggrowthcompany☐ LargeacceleratedfilerNon-accelerated filer If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with anynew or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm thatprepared or issued its audit report.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included inthe filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensationreceived by any of the registrant's executive officers during the relevant recovery period pursuant to § 240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act).Yes☐No☒The aggregate market value of shares of voting stock held by non-affiliates of the registrant was approximately $70,127,916 based on the last reported sale price of the registrant's Common Stock on October31, 2025, the last business day of the registrant's most recently completed secondfiscal quarter. Only shares beneficially owned by directors and executive officers of the registrant (excluding shares subject to options), each person considerations, may be deemed to control or significantly influence the management or policies of the registrant were excluded in that such personsmay be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes. As of June24,2026, the registrant had outstanding 2,870,410 shares of Common Stock. DOCUMENTS INCORPORATED BY REFERENCE: Those portions of the Company's proxy statement for use in connection with KewauneeScientific Corporation's annual meeting of stockholders to be held on August26, 2026, indicated in this report are incorporated by reference into TableofContents PART I Item 1.BusinessItem 1A.Risk FactorsItem 1B.Unresolved Staff Comments PART II Item 5.Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of EquitySecuritiesItem 6.Reserved.Item 7.Management's Discussion and Analysis of Financial Condition and Results of OperationsItem 7A.Quantitative and Qualitative Disclosures About Market RiskItem 8.Financial Statements and Supplementary DataItem 9.Changes in and Disagreements with Accountants on Accounting and Financial DisclosureItem 9A.Controls and ProceduresItem9B.Other InformationItem9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections PART III Item 10.Directors, Executive Officers and Corporate GovernanceItem 11.Executive CompensationItem 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder MattersItem 13.Certain Relationships and Related Transactions, and Director IndependenceItem 14.Principal Accountant Fees and Services PART IV Item 15.Exhibits and Financial Statement SchedulesItem 16.Form 10-K Summary EXHIBITINDEXSIGNATURES PART I SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities LitigationReform Act of 1995 (the "Reform Act"). All statements other than statements of historical fact included in this Annual Report,including statements regarding the Company's future financial condition,